Ling Xu
- Molecular Biology top 10%
- Cancer Research top 1%
- Oncology top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Surgery
- Co-authors
- Jerry L. NadlerRama NatarajanHua ZhangChunxiang ZhangJian YangYunhui ChengXiaojun LiuYujie Chen
- Topics
- Breast Cancer Treatment Studies (43 papers)HER2/EGFR in Cancer Research (32 papers)MicroRNA in disease regulation (14 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Ling Xu
125 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 109
- Molecular Biology 1.2k
- Cancer Research 1.1k
- Oncology 503
- Radiology, Nuclear Medicine and Imaging 261
- Surgery 249
Countries citing papers authored by Ling Xu
This map shows the geographic impact of Ling Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Xu more than expected).
Fields of papers citing papers by Ling Xu
This network shows the impact of papers produced by Ling Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Xu. The network helps show where Ling Xu may publish in the future.
Co-authorship network of co-authors of Ling Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Ling Xu. A scholar is included among the top collaborators of Ling Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Xu. Ling Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 3 | |
| 10 | 7 | |
| 11 | Thoracic Radiotherapy Benefits Elderly Extensive-Stage Small Cell Lung Cancer Patients with Distant Metastasis | 3 |
| 12 | 3 | |
| 13 | 2 | |
| 14 | [Analysis on clinical and pathological characteristics of 66 patients with stage IV breast cancer]. | 2 |
| 15 | 29 | |
| 16 | 10 | |
| 17 | 14 | |
| 18 | 1 | |
| 19 | Experimental study on reversion effect of elemene on multidrug resistance of human gastric cancer cell line | 4 |
| 20 | Effect of Xiaotan Sanjie Recipe on Expression of ICAM-1 in Gastric Carcinoma | 1 |
About Ling Xu
Ling Xu is a scholar working on Cancer Research, Oncology and Hepatology, having authored 129 papers that have together received 2.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (43 papers), HER2/EGFR in Cancer Research (32 papers) and MicroRNA in disease regulation (14 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (503 citations) and Molecular Biology (1.2k citations). Ling Xu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Jerry L. Nadler, Rama Natarajan, Hua Zhang, Chunxiang Zhang, Jian Yang, Yunhui Cheng, Xiaojun Liu, Yujie Chen, Noe Gonzales and Yusheng Zheng. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.